MetaVia, Inc. (MTVA)
1.84
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 13:15
MetaVia Total Liabilities (Quarterly) : 6.449M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.449M |
| March 31, 2026 | 5.315M |
| December 31, 2025 | 63.79M |
| September 30, 2025 | 8.434M |
| June 30, 2025 | 8.835M |
| March 31, 2025 | 7.747M |
| December 31, 2024 | 8.329M |
| September 30, 2024 | 9.193M |
| June 30, 2024 | 9.809M |
| March 31, 2024 | 6.942M |
| December 31, 2023 | 6.096M |
| September 30, 2023 | 4.875M |
| June 30, 2023 | 3.983M |
| March 31, 2023 | 10.98M |
| December 31, 2022 | 11.78M |
| September 30, 2022 | 1.619M |
| June 30, 2022 | 1.249M |
| March 31, 2022 | 1.533M |
| December 31, 2021 | 2.202M |
| September 30, 2021 | 1.952M |
| June 30, 2021 | 1.241M |
| Date | Value |
|---|---|
| March 31, 2021 | 1.009M |
| December 31, 2020 | 3.765M |
| September 30, 2020 | 3.692M |
| June 30, 2020 | 3.214M |
| March 31, 2020 | 3.795M |
| December 31, 2019 | 2.176M |
| September 30, 2019 | 3.073M |
| June 30, 2019 | 2.05M |
| March 31, 2019 | 1.712M |
| December 31, 2018 | 11.92M |
| September 30, 2018 | 14.02M |
| June 30, 2018 | 13.76M |
| March 31, 2018 | 14.02M |
| December 31, 2017 | 15.08M |
| September 30, 2017 | 16.26M |
| June 30, 2017 | 5.274M |
| March 31, 2017 | 4.545M |
| December 31, 2016 | 4.122M |
| September 30, 2016 | 1.936M |
| June 30, 2016 | 14.43M |
| March 31, 2016 | 9.044M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 2.555B |
| aTyr Pharma, Inc. | 21.23M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.27M |
| Shareholders Equity (Quarterly) | 6.822M |
| Debt to Equity Ratio | 0.0259 |
| Current Ratio | 2.059 |
| Net Debt Paydown Yield | -0.13% |